February 14, 2017
Sanofi Genzyme’s Phase 2 Clinical Trial to Evaluate Oral Substrate Reduction Therapy for Gaucher Disease Type 3
Read More
January 8, 2017
Nominate a Lysosomal Hero For the Sanofi Genzyme TORCH Awards
Read More
January 11, 2014
A Rare Disease Champion For Gaucher Disease
Read More
November 19, 2013
Why Rare Diseases are Big Pharma’s Latest Obsession
Read More
November 14, 2013
Shire to Pay $4.2 Billion for Rare Disease Firm ViroPharma
Read More
August 18, 2011
Genzyme Announces Winners of Patient Advocacy Leadership Award Grants
Read More
X